India's nutraceutical market is projected to reach $55-57 billion by 2030, expanding at a 10-11% annual rate. Driven by rising preventive healthcare demand and digital adoption, major FMCG companies are aggressively acquiring health-focused brands to capture this shift.
What Happened
India’s nutraceutical industry is on a steady growth path, with the market size expected to nearly double from approximately $29-30 billion in 2024 to between $55 billion and $57 billion by 2030. This growth, forecasted at an annual rate of 10-11%, reflects a fundamental shift in consumer behavior. As Indians increasingly move from reactive medical treatment to proactive health management, demand for supplements, functional foods, and beverages is rising. Industry reports indicate that functional foods and beverages currently dominate the sector, accounting for roughly 70% of total consumption, while dietary supplements make up the rest.
The FMCG Consolidation Trend
Large consumer goods companies are actively expanding their portfolios through strategic acquisitions to tap into this high-growth space. Rather than building from scratch, companies are acquiring established digital-first and nutrition-focused brands to gain immediate access to consumer insights and distribution channels. For instance, Hindustan Unilever (HUL) has fully acquired OZiva to strengthen its health and wellness offerings. Similarly, Honasa Consumer recently announced a majority stake acquisition in Fluence Pharma to enter the science-backed nutraceutical space. Marico has also expanded its wellness portfolio through investments in brands like Plix and Cosmix, while ITC has brought Yoga Bar into its fold. This M&A activity is driven by the need for these giants to diversify beyond traditional categories and reach younger, health-conscious cohorts.
Why Investors Are Watching Closely
For FMCG investors, the attraction lies in the high-margin potential of health and wellness products compared to some legacy consumer goods. However, scaling these acquired brands successfully remains a key test. The integration process requires combining the founders' innovation and brand agility with the corporate parent's scale, supply chain, and regulatory expertise. As these brands move from niche digital audiences to mass-market distribution, maintaining brand identity while managing customer acquisition costs will be critical for long-term profitability.
Regulatory and Market Risks
The sector is not without challenges. Because nutraceuticals sit at the intersection of food and medicine, regulatory compliance is complex. The Food Safety and Standards Authority of India (FSSAI) governs the sector, and companies face strict scrutiny regarding product labelling, health claims, and ingredient standards. The market also suffers from fragmentation, with many products struggling to meet quality benchmarks. Instances of underdosed ingredients or misleading health claims by smaller, unregulated players can sometimes cast a shadow on the broader industry's reputation. Navigating these compliance hurdles is essential for established companies to protect their brand equity.
What Investors Should Track
Going forward, investors may monitor three key areas: how effectively large companies integrate and scale their recent acquisitions, the trend in marketing and distribution spending as competition intensifies, and any changes in FSSAI regulations that could impact product approval timelines or labelling requirements. Success will likely depend on a company's ability to balance innovation with strict regulatory adherence.